Enhancing the Immunogenicity of RBD Protein Variants through Amino Acid E484 Mutation in SARS-CoV-2

In the context of the COVID-19 pandemic, conducting antibody testing and vaccination is critical. In particular, the continued evolution of SARS-CoV-2 raises concerns about the effectiveness of vaccines currently in use and the activity of neutralizing antibodies. Here, we used the Escherichia coli...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Zhikai, Wan, Xuan, Li, Xinyue, Cai, Shaoxi, Wan, Chengsong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9506138/
https://www.ncbi.nlm.nih.gov/pubmed/36146826
http://dx.doi.org/10.3390/v14092020

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9506138/
https://www.ncbi.nlm.nih.gov/pubmed/36146826
http://dx.doi.org/10.3390/v14092020

Ejemplares similares